Stallion India Fluorochemicals Faces Scrutiny Over Q3 Results, Apologizes for Reporting Errors

## Stallion India Fluorochemicals: Apology Over Reporting Errors, Q3 EBITDA Dips Amid Revenue Surge

Stallion India Fluorochemicals Limited (SIFL) has issued a significant clarification and apology to investors regarding perceived inconsistencies in its Q3 and Nine Months ended December 31, 2025 (FY26) financial performance communications. The company attributed these discrepancies to an "inadvertent communication lapse at the Investor Relations (IR) level," emphasizing that only official exchange filings are to be relied upon. This admission signals potential governance or internal control weaknesses that are now being addressed, with management stating controls are being strengthened.

### 📉 The Financial Deep Dive - Q3 Performance Analysis

The unaudited Q3 FY26 results presented a mixed picture:
*   **Total Revenue** surged by **23.17%** year-on-year to **₹10,487.90 Lakhs** from **₹8,515.09 Lakhs**.
*   However, **EBITDA** witnessed a decline of **5.21%** YoY, falling to **₹1,356.20 Lakhs** from **₹1,430.80 Lakhs**. This resulted in significant margin compression.
*   **Profit After Tax (PAT)** saw a rise of **12.42%** YoY to **₹1,112.69 Lakhs** from **₹977.54 Lakhs**.
*   A notable inconsistency was reported in **Earnings Per Share (EPS)**. While the absolute EPS reported was **₹1.40** (down from ₹1.59 in Q3 FY25), the company stated it as an "11.95% increase YoY from ₹1.59." This mathematical anomaly requires careful investor scrutiny.

### 📊 The Nine-Month Performance & Growth Narrative

Contrastingly, the cumulative nine-month (9M) performance for FY26 was exceptionally strong:
*   **Total Revenue** grew robustly by **41.69%** YoY to **₹32,118.21 Lakhs** from **₹22,668.25 Lakhs**.
*   **EBITDA** jumped by an impressive **48.57%** YoY to **₹4,369.91 Lakhs** from **₹2,941.33 Lakhs**, indicating improved operational efficiency over the longer term.
*   **PAT** recorded a substantial **72.81%** increase YoY, reaching **₹3,290.68 Lakhs** from **₹1,904.25 Lakhs**.
*   **EPS** grew by **33.87%** YoY to **₹4.15** from **₹3.10**.

Management reiterated its full-year FY26 targets of **₹43,000 Lakhs in revenue** and **₹4,000 Lakhs in PAT**. The company projects a strong **30-35% revenue CAGR** over the next three years, driven by higher volumes, an improved product mix, and expansion in specialty and industrial gases. Investments in HFO/HFC blending, semiconductor gases, liquid helium processing, and R-32 manufacturing are cited as key growth levers.

### 🚩 Risks & Outlook

The primary risk highlighted is the communication lapse itself, which could impact investor confidence. While the underlying business drivers appear strong, with significant growth in 9M and a promising outlook, execution of guidance and maintaining clear, accurate investor communication will be critical. Investors should monitor margin trends, particularly in the context of raw material costs and competitive pressures, alongside the successful integration of new product lines. The focus now shifts to how effectively the company strengthens its IR processes to prevent future recurrences and rebuild trust.